Cutaneous adverse drug reactions in children. A series of 90 cases

Aida Khaled1, Monia Kharfi, Myriam Ben Hamida

  • 1Department of Dermatology, Charles Nicolle Hospital, Tunis, Tunisia.

La Tunisie Medicale
|February 8, 2012
PubMed

Insights

Cutaneous adverse drug reactions (CADR) are common in children, with maculopapular eruptions caused by antibiotics being the most frequent. All children experienced favorable outcomes, even with severe reactions, highlighting the need for careful drug assessment.

Area of Science:

  • Pediatric Dermatology
  • Pharmacovigilance
  • Drug Safety

Background:

  • Cutaneous adverse drug reactions (CADR) are frequent in pediatric populations.
  • These reactions present with diverse clinical manifestations and can be triggered by various medications.

Purpose of the Study:

  • To investigate the epidemioclinical characteristics of CADR in Tunisian children.
  • To identify the specific drugs responsible for these reactions in the studied pediatric cohort.

Main Methods:

  • Retrospective analysis of 90 children under 16 with documented CADR over 18 years (1991-2008).
  • Data collected included patient demographics, lesion types, causative drugs, onset delay, and treatment outcomes.
  • Inclusion criteria required well-documented cutaneous drug reactions validated by the national pharmacovigilance center.

Main Results:

  • Maculopapular eruption (MPE) was the most common reaction (57.7%), followed by acute urticaria (16.6%) and fixed drug eruption (14.4%).
  • Antibiotics were the leading cause (55.5%), particularly betalactamins, followed by non-steroidal anti-inflammatory drugs (18.8%) and antiepileptics (11.1%).
  • All patients achieved a favorable outcome, including those with severe cutaneous drug reactions.

Conclusions:

  • Antibiotic-induced maculopapular eruptions are the predominant form of CADR in children.
  • Establishing definitive drug causality is crucial, considering the prevalence of MPE in infectious conditions and frequent antibiotic use in pediatrics.
Abstract

Related Concept Videos

Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...